Anafranil

Clomipramine

Utilized to support the management of obsessive-compulsive disorder.

Active ingredient
Clomipramine
Supply
Pharmacy
Route
Oral use
Form
Film-coated tablet
Strengths
10 · 25 · 50mg

Anafranil details

Therapeutic class
Tricyclic Antidepressant
Pharmacological class
TCA
Contraindications
recent myocardial infarction; maois
Precautions and warnings
sedative effects; avoid rapid discontinuation
Minor side effects
dry mouth; drowsiness; constipation
Moderate side effects
blurred vision; urinary retention; weight gain
Dosage forms
Film-coated tablet
Administration route
Oral use
Patient summary
utilized to support the management of obsessive-compulsive disorder.
Supply category
Pharmacist only, dispensed without a prescription
Manufacturer
Novartis
Onset Time
2–4 weeks
Duration
24 hours
Storage instructions
Store below 25°C.
Drug interactions
alcohol; maois; cimetidine
Age restrictions
Use with caution in children.
Pregnancy and breastfeeding
Consult doctor before use in pregnancy.
Serious side effects

arrhythmia, requires immediate medical attention; seizures, requires immediate medical attention

Mechanism of action

Clomipramine inhibits the neuronal reuptake of noradrenaline and serotonin, which helps balance neurotransmitter levels to alleviate symptoms.

Where this medicine is registered

  • Singapore
  • Hong Kong
  • Thailand
  • Malaysia
  • Philippines
  • Indonesia
  • Taiwan
  • South Korea
  • Japan
  • Australia
  • New Zealand
  • UAE
  • South Africa

About Anafranil

Anafranil features clomipramine, a treatment indicated for Obsessive-compulsive Disorder, Major Depressive Disorder and Phobic States. Produced by Novartis, the medication is supplied as a tablet in strengths of 10, 25 and 50mg.

Anafranil availability in Asia

Anafranil is registered across 14 markets, including Japan, the UAE and Singapore, with availability also in Hong Kong, Thailand and Malaysia. Generic clomipramine, much of which is manufactured in India, offers a more affordable alternative to the original brand for expats and patients located in areas that may have limited access to specific medications. This treatment should be used under a doctor’s care to monitor its effectiveness.